TMEM70
Transmembrane protein 70, mitochondrial
Also known as: FLJ20533, TMM70_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BUB7
- Gene
- TMEM70
- Ensembl
- ENSG00000175606
- Chromosome
- 8
- Canonical length
- 260 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Mitochondria
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene likely encodes a mitochondrial membrane protein. The encoded protein may play a role in biogenesis of mitochondrial ATP synthase. Mutations in this gene have been associated with neonatal mitochondrial encephalocardiomyopathy due to ATP synthase deficiency. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
Canonical amino-acid sequenceUniProt
260 residues, UniProt reviewed canonical sequence.
>Q9BUB7|TMEM70
1 MLFLALGSPW AVELPLCGRR TALCAAAALR GPRASVSRAS SSSGPSGPVA GWSTGPSGAA
61 RLLRRPGRAQ IPVYWEGYVR FLNTPSDKSE DGRLIYTGNM ARAVFGVKCF SYSTSLIGLT
121 FLPYIFTQNN AISESVPLPI QIIFYGIMGS FTVITPVLLH FITKGYVIRL YHEATTDTYK
181 AITYNAMLAE TSTVFHQNDV KIPDAKHVFT TFYAKTKSLL VNPVLFPNRE DYIHLMGYDK
241 EEFILYMEET SEEKRHKDDKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM70 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 95 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 95 nTPM
- liver: 24 nTPM
- pancreas: 23 nTPM
- tongue: 19 nTPM
- heart muscle: 18 nTPM
- adipose tissue: 18 nTPM
Single-cell type
- parietal cells: 186 nCPM
- hofbauer cells: 137 nCPM
- fallopian tube ciliated cells: 116 nCPM
- late primary spermatocytes: 109 nCPM
- decidual stromal cells: 104 nCPM
- syncytiotrophoblasts: 86 nCPM
Immune cell
- memory B-cell: 18 nTPM
- total PBMC: 12 nTPM
- plasmacytoid DC: 11 nTPM
- naive B-cell: 11 nTPM
- naive CD4 T-cell: 10 nTPM
- intermediate monocyte: 10 nTPM
Brain region
- cerebral cortex: 9.5 nTPM
- cerebellum: 8.5 nTPM
- hippocampal formation: 8.1 nTPM
- hypothalamus: 7.9 nTPM
- white matter: 7.7 nTPM
- pons: 7.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TMEM70.
Disease | AllUniProt
Conditions TMEM70 is implicated in, by any mechanism.
- Mitochondrial complex V deficiency, nuclear type 2 (MC5DN2) MIM:614052
Disease | GeneticClinVar
39 pathogenic / likely-pathogenic of 391 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2
- See cases
- Neurodevelopmental disorder
- TMEM70-related disorder
- Papillary renal cell carcinoma type 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.13
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mitochondrial proton-transporting ATP synthase complex assembly
- mitochondrial respiratory chain complex I assembly
- protein complex oligomerization
- protein homooligomerization
Molecular functions
- mitochondrial proton-transporting ATP synthase complex binding
- protein-macromolecule adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMEM70 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM70 as an antibody target. Whether an autoantibody or antibody against TMEM70 could matter depends on whether native TMEM70 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM70 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM70 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...